West Pharmaceutical Services Total Non-Operating Income/Expense 2010-2024 | WST

West Pharmaceutical Services annual/quarterly total non-operating income/expense history and growth rate from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
  • West Pharmaceutical Services total non-operating income/expense for the quarter ending September 30, 2024 was $0.003B, a 67.01% decline year-over-year.
  • West Pharmaceutical Services total non-operating income/expense for the twelve months ending September 30, 2024 was $0.018B, a 28.47% increase year-over-year.
  • West Pharmaceutical Services annual total non-operating income/expense for 2023 was $0.022B, a 140.67% decline from 2022.
  • West Pharmaceutical Services annual total non-operating income/expense for 2022 was $-0.054B, a 1491.18% increase from 2021.
  • West Pharmaceutical Services annual total non-operating income/expense for 2021 was $-0.003B, a 39.29% decline from 2020.
West Pharmaceutical Services Annual Total Non-Operating Income/Expense
(Millions of US $)
2023 $22
2022 $-54
2021 $-3
2020 $-6
2019 $-5
2018 $0
2017 $-3
2016 $-5
2015 $-13
2014 $-13
2013 $-15
2012 $-27
2011 $-17
2010 $-16
2009 $-14
West Pharmaceutical Services Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-09-30 $3
2024-06-30 $3
2024-03-31 $5
2023-12-31 $7
2023-09-30 $10
2023-06-30 $2
2023-03-31 $3
2022-12-31 $-1
2022-09-30 $-50
2022-06-30 $-1
2022-03-31 $-2
2021-12-31 $-2
2021-09-30 $-0
2021-06-30 $-0
2021-03-31 $-1
2020-12-31 $-1
2020-09-30 $-2
2020-06-30 $-2
2020-03-31 $-2
2019-12-31 $-1
2019-09-30 $-2
2019-06-30 $-1
2019-03-31 $-1
2018-12-31 $0
2018-09-30 $0
2018-06-30 $-0
2018-03-31 $0
2017-12-31 $-1
2017-09-30 $0
2017-06-30 $-1
2017-03-31 $-1
2016-12-31 $1
2016-09-30 $-2
2016-06-30 $-2
2016-03-31 $-2
2015-12-31 $-3
2015-09-30 $-3
2015-06-30 $-3
2015-03-31 $-4
2014-12-31 $-3
2014-09-30 $-3
2014-06-30 $-4
2014-03-31 $-4
2013-12-31 $-3
2013-09-30 $-4
2013-06-30 $-4
2013-03-31 $-4
2012-12-31 $-3
2012-09-30 $-4
2012-06-30 $-16
2012-03-31 $-4
2011-12-31 $-4
2011-09-30 $-4
2011-06-30 $-4
2011-03-31 $-5
2010-12-31 $-4
2010-09-30 $-4
2010-06-30 $-4
2010-03-31 $-4
2009-12-31 $-4
2009-09-30 $-4
2009-06-30 $-3
2009-03-31 $-4
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.024B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36